Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial
Year: 2025
Type: article
Language: en
Topic: Colorectal Cancer Treatments and Studies
Authors and affiliations:
raw_author_name: E. Elez
raw_affiliation_strings: Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
raw_author_name: S. Siena
raw_affiliation_strings: Università degli Studi di Milano, Niguarda Cancer Center and Department of Medical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
raw_author_name: A. Sartore-Bianchi
raw_affiliation_strings: Università degli Studi di Milano, Niguarda Cancer Center and Department of Medical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
raw_author_name: J. Ros
raw_affiliation_strings: Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
raw_author_name: F. Ciardello
raw_affiliation_strings: Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
raw_author_name: E. Martinelli
raw_affiliation_strings: Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
raw_author_name: N. Steeghs
raw_affiliation_strings: The Netherlands Cancer Institute, Amsterdam, The Netherlands; University Medical Center Utrecht, Utrecht, The Netherlands
raw_author_name: S. Huijberts
raw_affiliation_strings: KU Leuven, Leuven, Belgium; Amsterdam UMC, Amsterdam, The Netherlands
raw_author_name: A. Cervantes
raw_affiliation_strings: Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: S. Roselló
raw_affiliation_strings: Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
raw_author_name: S. Tejpar
raw_affiliation_strings: UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium; The Netherlands Cancer Institute, Amsterdam, The Netherlands
raw_author_name: B. Wilmsen
raw_affiliation_strings: KU Leuven, Leuven, Belgium; Amsterdam UMC, Amsterdam, The Netherlands
raw_author_name: R. Salazar
raw_affiliation_strings: Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain
raw_author_name: C. Santos
raw_affiliation_strings: Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain
raw_author_name: G. de Schaetzen
raw_affiliation_strings: EORTC Headquarters, Brussels, Belgium
raw_author_name: S. Muñoz
raw_affiliation_strings: Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
raw_author_name: R. Bernards
raw_affiliation_strings: UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium; The Netherlands Cancer Institute, Amsterdam, The Netherlands
raw_author_name: V. Moreno
raw_affiliation_strings: Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and University of Barcelona Institute of Complex Systems (UBICS), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
raw_author_name: E. García-Galera
raw_affiliation_strings: Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: R. Alemany
raw_affiliation_strings: Catalan Institute of Oncology, Oncobell Program (IDIBELL), University of Barcelona (Campus Bellvitge), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain
raw_author_name: A. Gros
raw_affiliation_strings: Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
raw_author_name: A. Bardelli
raw_affiliation_strings: Department of Oncology, University of Torino, Torino, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy
raw_author_name: S. Arena
raw_affiliation_strings: Department of Oncology, University of Torino, Torino, Italy; Candiolo Cancer Institute, FPO-IRCS, Candiolo, Torino, Italy
raw_author_name: A. Piris
raw_affiliation_strings: Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
raw_author_name: E. Chavarría
raw_affiliation_strings: Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain
raw_author_name: R. Dienstmann
raw_affiliation_strings: Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; University of Vic - Central University of Catalonia, Vic, Spain
raw_author_name: J. Tabernero
raw_affiliation_strings: Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: jtabernero@vhio.net